COVID-19 Treatment Tracker 2020



Worldwide Stats


Confirmed Cases:
Active Cases:
Deaths:
Recovered:
Next Treatment Releases
  • Days
  • Hours
  • Minutes
  • Seconds

Worldwide Stats


Confirmed Cases Today:
Deaths Today:
Tests:
Countries Affected:






Common symptoms include:
- Fever
- Tiredness
- Dry cough


Other symptoms include:
- Shortness of breath
- Aches and pains
- Sore throat
- Very few people will report diarrhoea, nausea or a runny nose

NOTICE: PLEASE FOLLOW YOUR LOCAL GOVERNMENTS ADVICE FOR MORE DETAILED INSTRUCTIONS



Methods Of Prevention:

- Wash your hands regularly with soap and water, or clean them with alcohol-based hand rub.
- Maintain at least 1 metre distance between you and people coughing or sneezing.
- Avoid touching your face.
- Cover your mouth and nose when coughing or sneezing.
- Stay home if you feel unwell.
- Refrain from smoking and other activities that weaken the lungs.
- Practice physical distancing by avoiding unnecessary travel and staying away from large groups of people.
Source: World Health Organisation (WHO)

Type Name Progress Estimated Release

Treatment Antibodies from recovered COVID-19 patients (1)
July 2020
Treatment Antibodies from recovered COVID-19 patients (2)
July 2020
Treatment Gilenya (fingolimod), sphingosine 1-phosphate receptor modulator
July 2020
Treatment Antibodies from recovered COVID-19 patients (3)
August 2020
Treatment Polyclonal hyperimmune globulin (H-IG)
August 2020
Treatment Horse plasma product (COVID-EIG)
August 2020
Treatment Prezcobix (darunavir, HIV-1 protease inhibitor/cobicistat, CYP3A inhibitor)
August 2020
Vaccine CoroFlu, self-limiting influenza virus
September 2020
Vaccine Unknown (SK Biosciences)
September 2020
Vaccine Non-replicating viral vector; Ad26 (alone or with MVA boost)
September 2020
Vaccine Self-assembling vaccine (fusion protein of a heat shock protein and Avidin)
October 2020


Type Name Progress Estimated Release

Treatment Actemra (tocilizumab), interleukin-6 receptor antagonist
Apr-20
Treatment Gimsilumab, antigranulocyte-macrophage colony stimulating factor monoclonal
Apr-20
Treatment Sylvant (siltuximab), interleukin-6 targeted monoclonal
Apr-20
Treatment LY3127804, antiAngiopoietin 2 (Ang2) antibody
Apr-20
Treatment Favilavir/Favipiravir/T-705/ Avigan, licensed in Japan to treat influenza
Apr-20
Treatment galidesivir
Apr-20
Treatment EIDD-2801, oral ribonucleoside analog
Apr-20
Treatment CYNK-001, allogeneic, natural killer cell therapy
Apr-20
Treatment Peginterferon lambda
Apr-20
Treatment APN01; recombinant soluble human Angiotensin Converting Enzyme 2
Apr-20
Treatment nafamostat, approved in Japan to treat pancreatitis and other diseases
Apr-20
Treatment ARMS-1
Apr-20
Treatment CD24Fc, biological immunomodulator
Apr-20
Treatment Aviptadil, synthetic form of Vasoactive Intestinal Polypeptide
Apr-20
Treatment vazegepant, CGRP receptor antagonist
Apr-20
Treatment CM4620-IE, calcium releaseactivated calcium (CRAC) channel inhibtor
Apr-20
Treatment CytoSorb (blood purification device, extracorporeal cytokine adsorber)
Apr-20
Treatment Extracorporeal blood purification (EBP) devices
Apr-20
Vaccine DNA (vaccine)
Apr-20
Vaccine Inactivated (formaldehydeinactivated + alum) (vaccine)
Apr-20
Vaccine Non-replicating viral vector; ChAdOx1 (vaccine)
Apr-20
Vaccine Non-replicating viral vector; Adenovirus Type 5 vector (Ad5- nCoV)
Apr-20
Vaccine Protein subunit, adjuvanted microsphere peptide
Apr-20
Vaccine Replicating viral vector; measles vector
Apr-20
Vaccine RNA; BNT162
Apr-20
Vaccine RNA; liposome-encapsulated mRNA
Apr-20
Treatment PD-1 blocking antibody; Thymosin
May 2020
Treatment Methylprednisolone / ciclesonide/ hydrocortisone/ corticosteroids
May 2020
Treatment remdesivir, nucleotide analog
May 2020
Treatment ASC09, HIV protease inhibitor
May 2020
Treatment Artifical intellegencebased screening to identify repurposed drug combinations
May 2020
Treatment LAU-7b (fenretinide)
May 2020
Vaccine NVX-CoV2373; Protein subunit; Full length S trimers/nanoparticle + Matrix M
May 2020
Vaccine PittCoVacc, Protein subunit, microneedle arrays S1 subunit
June 2020
Vaccine Protein subunit; S protein
June 2020
Vaccine RNA; LNP-encapsulated mRNA (mRNA 1273
June 2020
Vaccine RNA; mRNA
June 2020
Treatment Antibodies targeting the S protein from convalescent serum, humanized mice
June 2020
Treatment Antibody
June 2020
Treatment SAB-185, Polyclonal hyperimmune globulin (H-IG)
June 2020
Treatment Chloroquine/ Hydroxychloroquine, antimalarial
June 2020
Vaccine Deoptimized live attenuated virus
June 2020
Vaccine DPX-COVID-19, protein subunit, lipid-based delivery platform
June 2020
Vaccine LUNAR-COV19; RNA; mRNA
June 2020
Vaccine RNA; saRNA
June 2020
Treatment Antibodies from mice, REGN3048-3051, against the spike protein
June 2020




What work is being done to find treatments?

Over 150 different drugs are being researched (we only named the ones with confirmed release dates). Most of the ones being tested are existing drugs that have been used to treat other diseases before. The World Health Organization (WHO) has launched the Solidarity trial aimed at assessing the most promising treatments The UK says its Recovery trial is the world's biggest, with more than 5,000 patients already taking part And multiple research centres around the world are attempting to use survivors' blood as a treatment What types of drugs might work? There are three broad approaches being investigated: Antiviral drugs that directly affect the coronavirus's ability to thrive inside the body Drugs that can calm the immune system - patients become seriously ill when their immune system overreacts and starts causing collateral damage to the body Antibodies, either from survivors' blood or made in a lab, that can attack the virus What is the most promising coronavirus drug? Dr Bruce Aylward, from the World Health Organization, said remdesivir was the only drug that showed any signs of effectiveness, after he visited China. The antiviral drug was originally designed to treat Ebola, but other options proved more effective. It has since been shown to be effective at treating other deadly coronaviruses (Middle East respiratory syndrome and severe acute respiratory syndrome) in animal studies, leading to hopes it will also be effective against the Covid-19 coronavirus.
Source: BBC



Help page:

This site is a list of all of the treatments and vaccines (with confirmed dates) being developed and tested. This list is not 100% accurate, so there might be some items missing that should be there, we are working with what we can find on the internet to put together this site. If you see anything that is missing that you think should be on the site, feel free to email us and we will be happy to review your email and make a change to the site.


Contact Us:

CovidCures@gmail.com






Useful Websites:Sources:



Largest variety of Drugs:

1st America: 35
2nd China: 9
3rd United Kingdom: 7
Research Centres:



Largest amount of Drugs:

1st America: 40
2nd United Kingdom: 14
3rd China: 9



©CovidCuresTrackerHelp the siteCovidCures@gmail.comPrivacy PolicyDisclaimerCookies